|
Healthy People Home > Healthy People 2020 >
Secretary's Advisory Committee >
First Meeting
Minutes > Appendix B |
First Meeting: January 31-February 1, 2008 |
|
Appendix B
Jonathan E. Fielding
Introductory Comments on 2020 Health Objective to the Nation
January 31, 2008
- What can we learn from past objectives?
- What can we learn from how those objectives were developed?
- What conceptual frameworks were utilized?
- What process was employed?
- Who has used them?
-
Federal government
-
State government
-
Local government
-
Voluntary organizations
-
Business
-
Educational institutions
-
Community groups
-
Other
- How have they been used by each of these groups, and to what extent?
- Why have we gotten closer to some objectives than others?
-
More realistic objectives?
-
Better use of evidence based strategies?
-
Other factors e.g. HEDIS, pay for performance, etc.
- What cross cutting lessons can be learned?
- What can we learn from other nations that have developed health
objectives?
- Who should be the primary and secondary target audiences for the
2020 objectives?
-
How do we decide?
-
How do we get the best input?
-
How do we efficiently reach those groups?
- Who are the principal stakeholders for the 2020 Objectives?
-
How can their differing perspectives be understood and, to the degree
possible, reconciled?
- Overall goals and objectives
-
Increase healthy years of life
-
Reduce disparities
-
Modify a and/or b
-
Add or subtract
- How can we best conceptualize the opportunities to maximize health
improvement?
- In the overall population
-
In reducing subgroup disparities by:
-
Race Ethnicity
-
Gender
-
Age
-
Place
-
How do we prioritize those opportunities?
- Burden
- Reducible burden
- Financial considerations
-
Costs
-
Costs vs. savings
-
Cost effectiveness/ health effectiveness
- Ease of implementation
- Other criteria
- What alternative approaches can be used to organize objectives?
-
Diseases/ injuries
-
Risk factors
-
Life stages
-
Underlying determinants
-
Combinations of a-d
-
Implications of choices for likelihood of disparity reductions
- What is the role of evidence?
-
In development of quantifiable objectives
-
In making assumptions about potential health improvement
-
Population effects
-
Distribution of benefits/ harms
-
Criteria for identifying evidence of effectiveness
-
Systematic reviews
-
As part of broad effort (e.g. Community Preventive Services Task Force,
Cochrane Collaboration, etc.)
-
Individual reviews
-
U.S. versus international
-
Other types of evidence
- What is the appropriate degree of emphasis on policy change (public
and private)?
-
Role in Health Objectives 2020
-
Evidence based
-
The challenge of conflicting perspectives on role of government
- Ability to track progress
-
Are there reliable/ valid measures for each Objective?
-
Are baseline measures available, at what level of aggregation?
-
Are there standardized data collection systems for tracking interim
changes?
-
Is there a coordinated data collection, analysis and dissemination
plan?
- Pathways and roles
-
Roadmaps for progress towards objectives
-
Roles of different entities
-
Emphasis on collaborative efforts
-
U.S. alone versus collaborations among nations
The hardest questions:
- How would our expectations of health in 2020 change if there were no
2020 Objectives for the Nation?
- How can our advice add the most health to the base case for 2020?
|
|
Content for this site is maintained by the
Office of Disease Prevention
& Health Promotion, U.S. Department
of Health and Human Services.
Last revised: July 9, 2008
|